U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Rocuronium Bromide Injection
Status: Currently in Shortage
»Date first posted: 02/15/2023
»Therapeutic Categories: Anesthesia

Expand all

Baxter Healthcare (Reverified 07/17/2024)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) Available Tamarang is the application holder and Baxter is the distributor/labeler
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) Available Tamarang is the application holder and Baxter is the distributor/labeler

Eugia US LLC (Reverified 07/17/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 100 mg/10 mL (NDC 55150-226-10) Available Check wholesalers for inventory
Injection, 50 mg/5 mL (NDC 55150-225-05) Available Check wholesalers for inventory

Fresenius Kabi USA, LLC (Reverified 07/16/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 63323-426-05) Available Check wholesalers for inventory
Injection, 10 mg/1 mL (NDC 63323-426-10) Available Check wholesalers for inventory
Injection, 10 mg/1 mL (NDC 65219-065-05) Available 7 month expiry available upon request; Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 07/01/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide Injection, Injection, 10 mg/1 mL (NDC 0143-9250-10) Available Additional lots will be available. Product will be made available as it is released.
Rocuronium Bromide Injection, Injection, 10 mg/1 mL (NDC 0143-9251-10) Available Additional lots will be available. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) Available
Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) Available
Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) Available
Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) Available

Meitheal Pharmaceuticals, Inc. (Reverified 07/03/2024)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 71288-700-06) Available
Injection, 10 mg/1 mL (NDC 71288-718-11) Available

Mylan Institutional, a Viatris Company (Reverified 07/18/2024)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) Available
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) Available

Piramal Critical Care Inc. (Revised 06/26/2024)

Company Contact Information:
800-414-1901

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 50 mg/5 mL (NDC 66794-228-41) Limited Availability Demand increase for the drug
Injection, 100 mg/10 mL (NDC 66794-229-41) Available

Sagent Pharmaceuticals (Reverified 07/01/2024)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 25021-687-05) Available

Sandoz Inc. (Reverified 07/19/2024)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 0781-3220-95) Available
Injection, 10 mg/1 mL (NDC 0781-3220-92) Available

XGen Pharmaceuticals DJB, Inc. (Reverified 07/16/2024)

Company Contact Information:
866-390-4411

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 50 mg/5 mL (NDC 39822-4200-2) Available Tamarang is the application holder and X-Gen is the distributor/labeler
Injection, 100 mg/10 mL (NDC 39822-4200-6) Available Tamarang is the application holder and X-Gen is the distributor/labeler
Back to Top